1. Home
  2. BLZE vs VNDA Comparison

BLZE vs VNDA Comparison

Compare BLZE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$3.63

Market Cap

218.8M

Sector

Technology

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.95

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
VNDA
Founded
2007
2002
Country
United States
United States
Employees
320
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.8M
474.0M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
BLZE
VNDA
Price
$3.63
$6.95
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$7.60
$14.90
AVG Volume (30 Days)
586.2K
1.6M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
58.56
N/A
EPS
N/A
N/A
Revenue
$145,835,000.00
$216,105,000.00
Revenue This Year
$10.28
$21.35
Revenue Next Year
$11.03
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
14.27
8.72
52 Week Low
$3.26
$3.81
52 Week High
$10.86
$9.91

Technical Indicators

Market Signals
Indicator
BLZE
VNDA
Relative Strength Index (RSI) 46.31 42.47
Support Level $3.61 $4.39
Resistance Level $5.04 $8.29
Average True Range (ATR) 0.15 0.44
MACD 0.02 -0.14
Stochastic Oscillator 78.32 16.93

Price Performance

Historical Comparison
BLZE
VNDA

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: